The FDA is moving BPC-157, Epitalon, MOTS-c, and 9 other peptides out of the "significant safety risk" category.
They now go to an independent expert review starting in July.
Not cleared yet, but the process is finally starting.
Big milestone for @SunHydrogenInc 🌞💧
Yesterday, we delivered our first housing unit and support structure to the University of Texas–based ProtoHub, operated by Michael Lewis and @GTIEnergy. A major step for hydrogen innovation in the U.S. 🇺🇸
SunHydrogen’s Tim Young & Hans-Peter Klein visited Niigata, Japan, for preliminary testing of the housing unit for our 1.92m² hydrogen modules. After a successful test, the unit is now en route to Iowa for integration—an exciting step toward commercial scale! #greenhydrogen